Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 2/20 | 0.32 |
| ▸ | LIMK2 | P53671 | 2/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | F7 | P08709 | 1/20 | 0.32 |
| ▸ | F3 | P13726 | 1/20 | 0.32 |
| ▸ | C1R | P00736 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25083076 | 1.00 | LIMK1 (0.32) | LIMK1LIMK2F2F10F7 | |
| SCHEMBL25083078 | 0.87 | F2 (0.31) | F2F10F7F3C1R | |
| SCHEMBL31068045 | 0.87 | F2 (0.31) | F2F10F7F3C1R | |
| SCHEMBL15972092 | 0.86 | LIMK1 (0.33) | LIMK1LIMK2C1RALDH1A1 | |
| SCHEMBL950314 | 0.86 | DHODH (0.40) | F2F10F7F3C1R | |
| SCHEMBL12528253 | 0.86 | CYP1A2 (0.35) | F2F10F7F3C1R | |
| SCHEMBL951016 | 0.86 | PDPK1 (0.36) | F2F10F7F3C1R | |
| SCHEMBL15971589 | 0.84 | RAB9A (0.35) | LIMK1LIMK2 | |
| SCHEMBL15971433 | 0.84 | LIMK1 (0.34) | LIMK1LIMK2F2F10F7 | |
| SCHEMBL25083045 | 0.84 | DHODH (0.36) | F2F10F7F3C1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240251795-A1 | METHOD FOR CONTROLLING DIAMIDE RESISTANT PESTS & COMPOUNDS THEREFOR | SYNGENTA CROP PROTECTION AG (CH) | 2024-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240251795-A1 | METHOD FOR CONTROLLING DIAMIDE RESISTANT PESTS & COMPOUNDS THEREFOR | DDT, NOS1, SLC11A2 | LIMK1 2549/4885LIMK2 3248/4885F2 1711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.